Biological role of prolyl 3-hydroxylation in type IV collagen

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 1, 2014, Pages 161-166

  Pokidysheva, Elena ^a,b   Boudko, Sergei ^a,b   Vranka, Janice ^c   Zientek, Keith ^a   Maddox, Kerry ^d   Moser, Markus ^e   Fässler, Reinhard ^e   Ware, Jerry ^f   Bächinger, Hans Peter ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (United States)

^b Department of Biochemistry and Molecular Biology ^*  (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GLYCOPROTEIN VI; OXYGENASE; PROLINE 3 HYDROXYLASE; PROLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BLOOD CLOTTING; CELL VIABILITY; CONTROLLED STUDY; EMBRYO DEATH; EMBRYO DEVELOPMENT; EXPOSURE; FEMALE; FERTILITY; HYDROXYLATION; KNOCKOUT MOUSE; LETHALITY; MATERNAL BLOOD; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; THROMBOCYTE AGGREGATION; THROMBOSIS;

AMINO ACID SEQUENCE; ANIMALS; BLOOD COAGULATION; CATTLE; COLLAGEN TYPE IV; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROXYLATION; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PHENOTYPE; PLATELET AGGREGATION; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTEIN STRUCTURE, TERTIARY; THROMBOSIS; TIME FACTORS;

EID: 84891960136     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1307597111     Document Type: Article

References (33)

1. Bächinger HP, Mizuno K, Vranka J, Boudko S (2010) Collagen formation and structure. Comprehensive Natural Products II: Chemistry and Biology, eds Mander L, Liu HW (Elsevier, Oxford), pp 469-530.
2. Khoshnoodi J, Pedchenko V, Hudson BG (2008) Mammalian collagen IV. Microsc Res Tech 71(5): 357-370.
3. Myllyharju J (2005) Intracellular post-translational modifications of collagens. Collagen. Primer in Structure, Processing and Assembly, eds Brinckmann J, Notbohm H, Muller PK (Springer, Berlin, Heidelberg), Vol 247, pp 115-147.
4. Vranka JA, Sakai LY, Bächinger HP (2004) Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J Biol Chem 279(22): 23615-23621.
5. Marini JC, Cabral WA, Barnes AM (2010) Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell Tissue Res 339(1): 59-70.
6. Vranka JA, et al. (2010) Prolyl 3-hydroxylase 1 null mice display abnormalities in fibrillar collagen-rich tissues such as tendons, skin, and bones. J Biol Chem 285(22): 17253-17262.
7. Fernandes RJ, Farnand AW, Traeger GR, Weis MA, Eyre DR (2011) A role for prolyl 3-hydroxylase 2 in post-translational modification of fibril-forming collagens. J Biol Chem 286(35): 30662-30669.
8. Tiainen P, Pasanen A, Sormunen R, Myllyharju J (2008) Characterization of recombinant human prolyl 3-hydroxylase isoenzyme 2, an enzyme modifying the basement membrane collagen IV. J Biol Chem 283(28): 19432-19439.
9. Schuppan D, Glanville RW, Timpl R, Dixit SN, Kang AH (1984) Sequence comparison of pepsin-resistant segments of basement-membrane collagen alpha 1(IV) chains from bovine lens capsule and mouse tumour. Biochem J 220(1): 227-233.
10. Leivo I, Wartiovaara J (1989) Basement membrane matrices in mouse embryogenesis, teratocarcinoma differentiation and in neuromuscular maturation. Int J Dev Biol 33(1): 81-89.
11. Theiler K (1989) The House Mouse: Atlas of Embryonic Development (Springler, New York).
12. Pöschl E, et al. (2004) Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 131(7): 1619-1628.
13. Holster T, et al. (2007) Loss of assembly of the main basement membrane collagen, type IV, but not fibril-forming collagens and embryonic death in collagen prolyl 4-hydroxylase I null mice. J Biol Chem 282(4): 2512-2519.
14. Moroi M, Jung SM (2004) Platelet glycoprotein VI: Its structure and function. Thromb Res 114(4): 221-233.
15. Knight CG, et al. (1999) Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc Res 41(2): 450-457.
16. Asselin J, Knight CG, Farndale RW, Barnes MJ, Watson SP (1999) Monomeric (glycineproline- hydroxyproline)10 repeat sequence is a partial agonist of the platelet collagen receptor glycoprotein VI. Biochem J 339(Pt 2): 413-418.
17. Packham MA, Mustard JF (1984) Platelet adhesion. Prog Hemost Thromb 7: 211-288.
18. Jung SM, et al. (2008) Collagen-type specificity of glycoprotein VI as a determinant of platelet adhesion. Platelets 19(1): 32-42.
19. Kato K, et al. (2003) The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 102(5): 1701-1707.
20. Tober J, et al. (2007) The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis. Blood 109(4): 1433-1441.
21. Parkin JD, et al. (2011) Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes. Hum Mutat 32(2): 127-143.
22. Mordechai S, et al. (2011) High myopia caused by a mutation in LEPREL1, encoding prolyl 3-hydroxylase 2. Am J Hum Genet 89(3): 438-445.
23. Croft SA, et al. (2001) Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation 104(13): 1459-1463.
24. Takagi S, et al. (2002) A GPVI polymorphism is a risk factor for myocardial infarction in Japanese. Atherosclerosis 165(2): 397-398.
25. Cole VJ, et al. (2003) Collagen platelet receptor polymorphisms integrin alpha2beta1 C807T and GPVI Q317L and risk of ischemic stroke. J Thromb Haemost 1(5): 963-970.
26. Joutsi-Korhonen L, et al. (2003) The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 101(11): 4372-4379.
27. Best D, et al. (2003) GPVI levels in platelets: Relationship to platelet function at high shear. Blood 102(8): 2811-2818.
28. Sokol J, et al. (2012) Platelet aggregation abnormalities in patients with fetal losses: The GP6 gene polymorphism. Fertil Steril 98(5): 1170-1174.
29. Kwak-Kim J, Yang KM, Gilman-Sachs A (2009) Recurrent pregnancy loss: A disease of inflammation and coagulation. J Obstet Gynaecol Res 35(4): 609-622.
30. Shah R, et al. (2009) The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. Br J Cancer 100(10): 1687-1696.
31. Labelle M, Hynes RO (2012) The initial hours of metastasis: The importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov 2(12): 1091-1099.
32. Buergy D, Wenz F, Groden C, Brockmann MA (2012) Tumor-platelet interaction in solid tumors. Int J Cancer 130(12): 2747-2760.
33. Jain S, Russell S, Ware J (2009) Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models. J Thromb Haemost 7(10): 1713-1717.